Abstract
Summary
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global Rabies Vaccine market is projected to reach US$ 1229.1 million by 2030 from an estimated US$ 971.4 million in 2024, at a CAGR of 4.0% during 2024 and 2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rabies Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Rabies Vaccine market is projected to reach US$ 1229.1 million by 2030 from an estimated US$ 971.4 million in 2024, at a CAGR of 4.0% during 2024 and 2030.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.
The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rabies Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine Market Size Estimates and Forecasts
2.1.1 Global Rabies Vaccine Revenue 2019-2030
2.1.2 Global Rabies Vaccine Sales 2019-2030
2.2 Rabies Vaccine Market Size by Region: 2023 Versus 2030
2.3 Rabies Vaccine Sales by Region (2019-2030)
2.3.1 Global Rabies Vaccine Sales by Region: 2019-2024
2.3.2 Global Rabies Vaccine Sales Forecast by Region (2025-2030)
2.3.3 Global Rabies Vaccine Sales Market Share by Region (2019-2030)
2.4 Rabies Vaccine Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Rabies Vaccine Revenue by Region: 2019-2024
2.4.2 Global Rabies Vaccine Revenue Forecast by Region (2025-2030)
2.4.3 Global Rabies Vaccine Revenue Market Share by Region (2019-2030)
3 Global Rabies Vaccine by Manufacturers
3.1 Global Top Rabies Vaccine Manufacturers by Sales
3.1.1 Global Rabies Vaccine Sales by Manufacturer (2019-2024)
3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Rabies Vaccine Manufacturers by Revenue
3.2.1 Global Rabies Vaccine Revenue by Manufacturer (2019-2024)
3.2.2 Global Rabies Vaccine Revenue Share by Manufacturer (2019-2024)
3.3 Global Rabies Vaccine Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Rabies Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Rabies Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Rabies Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Rabies Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK (Novartis)
4.1.1 GSK (Novartis) Company Information
4.1.2 GSK (Novartis) Description, Business Overview
4.1.3 GSK (Novartis) Rabies Vaccine Products Offered
4.1.4 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.5 GSK (Novartis) Rabies Vaccine Sales by Product in 2023
4.1.6 GSK (Novartis) Rabies Vaccine Sales by Application in 2023
4.1.7 GSK (Novartis) Rabies Vaccine Sales by Geographic Area in 2023
4.1.8 GSK (Novartis) Recent Developments
4.2 Sanofi-Pasteur
4.2.1 Sanofi-Pasteur Company Information
4.2.2 Sanofi-Pasteur Description, Business Overview
4.2.3 Sanofi-Pasteur Rabies Vaccine Products Offered
4.2.4 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Sanofi-Pasteur Rabies Vaccine Sales by Product in 2023
4.2.6 Sanofi-Pasteur Rabies Vaccine Sales by Application in 2023
4.2.7 Sanofi-Pasteur Rabies Vaccine Sales by Geographic Area in 2023
4.2.8 Sanofi-Pasteur Recent Developments
4.3 Chengda
4.3.1 Chengda Company Information
4.3.2 Chengda Description, Business Overview
4.3.3 Chengda Rabies Vaccine Products Offered
4.3.4 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Chengda Rabies Vaccine Sales by Product in 2023
4.3.6 Chengda Rabies Vaccine Sales by Application in 2023
4.3.7 Chengda Rabies Vaccine Sales by Geographic Area in 2023
4.3.8 Chengda Recent Developments
4.4 Yisheng
4.4.1 Yisheng Company Information
4.4.2 Yisheng Description, Business Overview
4.4.3 Yisheng Rabies Vaccine Products Offered
4.4.4 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Yisheng Rabies Vaccine Sales by Product in 2023
4.4.6 Yisheng Rabies Vaccine Sales by Application in 2023
4.4.7 Yisheng Rabies Vaccine Sales by Geographic Area in 2023
4.4.8 Yisheng Recent Developments
4.5 Prcmise
4.5.1 Prcmise Company Information
4.5.2 Prcmise Description, Business Overview
4.5.3 Prcmise Rabies Vaccine Products Offered
4.5.4 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Prcmise Rabies Vaccine Sales by Product in 2023
4.5.6 Prcmise Rabies Vaccine Sales by Application in 2023
4.5.7 Prcmise Rabies Vaccine Sales by Geographic Area in 2023
4.5.8 Prcmise Recent Developments
4.6 VACN
4.6.1 VACN Company Information
4.6.2 VACN Description, Business Overview
4.6.3 VACN Rabies Vaccine Products Offered
4.6.4 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.5 VACN Rabies Vaccine Sales by Product in 2023
4.6.6 VACN Rabies Vaccine Sales by Application in 2023
4.6.7 VACN Rabies Vaccine Sales by Geographic Area in 2023
4.6.8 VACN Recent Development
4.7 Changsheng
4.7.1 Changsheng Company Information
4.7.2 Changsheng Description, Business Overview
4.7.3 Changsheng Rabies Vaccine Products Offered
4.7.4 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Changsheng Rabies Vaccine Sales by Product in 2023
4.7.6 Changsheng Rabies Vaccine Sales by Application in 2023
4.7.7 Changsheng Rabies Vaccine Sales by Geographic Area in 2023
4.7.8 Changsheng Recent Development
4.8 BCHT
4.8.1 BCHT Company Information
4.8.2 BCHT Description, Business Overview
4.8.3 BCHT Rabies Vaccine Products Offered
4.8.4 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.5 BCHT Rabies Vaccine Sales by Product in 2023
4.8.6 BCHT Rabies Vaccine Sales by Application in 2023
4.8.7 BCHT Rabies Vaccine Sales by Geographic Area in 2023
4.8.8 BCHT Recent Development
4.9 Hissen
4.9.1 Hissen Company Information
4.9.2 Hissen Description, Business Overview
4.9.3 Hissen Rabies Vaccine Products Offered
4.9.4 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Hissen Rabies Vaccine Sales by Product in 2023
4.9.6 Hissen Rabies Vaccine Sales by Application in 2023
4.9.7 Hissen Rabies Vaccine Sales by Geographic Area in 2023
4.9.8 Hissen Recent Development
5 Breakdown Data by Type
5.1 Global Rabies Vaccine Sales by Type (2019-2030)
5.1.1 Global Rabies Vaccine Sales by Type (2019-2024)
5.1.2 Global Rabies Vaccine Sales Forecast by Type (2025-2030)
5.1.3 Global Rabies Vaccine Sales Market Share by Type (2019-2030)
5.2 Global Rabies Vaccine Revenue Forecast by Type (2019-2030)
5.2.1 Global Rabies Vaccine Revenue by Type (2019-2024)
5.2.2 Global Rabies Vaccine Revenue Forecast by Type (2025-2030)
5.2.3 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)
5.3 Rabies Vaccine Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Rabies Vaccine Sales by Application (2019-2030)
6.1.1 Global Rabies Vaccine Sales by Application (2019-2024)
6.1.2 Global Rabies Vaccine Sales Forecast by Application (2025-2030)
6.1.3 Global Rabies Vaccine Sales Market Share by Application (2019-2030)
6.2 Global Rabies Vaccine Revenue Forecast by Application (2019-2030)
6.2.1 Global Rabies Vaccine Revenue by Application (2019-2024)
6.2.2 Global Rabies Vaccine Revenue Forecast by Application (2025-2030)
6.2.3 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)
6.3 Rabies Vaccine Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Rabies Vaccine Market Size YoY Growth 2019-2030
7.2 North America Rabies Vaccine Market Facts & Figures by Country
7.2.1 North America Rabies Vaccine Sales by Country (2019-2030)
7.2.2 North America Rabies Vaccine Revenue by Country (2019-2030)
7.3 North America Rabies Vaccine Sales by Type (2019-2024)
7.4 North America Rabies Vaccine Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Rabies Vaccine Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Rabies Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Rabies Vaccine Sales by Region (2019-2030)
8.2.2 Asia-Pacific Rabies Vaccine Revenue by Region (2019-2030)
8.3 Asia-Pacific Rabies Vaccine Sales by Type (2019-2024)
8.4 Asia-Pacific Rabies Vaccine Sales by Application (2019-2024)
9 Europe
9.1 Europe Rabies Vaccine Market Size YoY Growth 2019-2030
9.2 Europe Rabies Vaccine Market Facts & Figures by Country
9.2.1 Europe Rabies Vaccine Sales by Country (2019-2030)
9.2.2 Europe Rabies Vaccine Revenue by Country (2019-2030)
9.3 Europe Rabies Vaccine Sales by Type (2019-2024)
9.4 Europe Rabies Vaccine Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Rabies Vaccine Market Size YoY Growth 2019-2030
10.2 Latin America Rabies Vaccine Market Facts & Figures by Country
10.2.1 Latin America Rabies Vaccine Sales by Country (2019-2030)
10.2.2 Latin America Rabies Vaccine Revenue by Country (2019-2030)
10.3 Latin America Rabies Vaccine Sales by Type (2019-2024)
10.4 Latin America Rabies Vaccine Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Rabies Vaccine Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Rabies Vaccine Sales by Country (2019-2030)
11.2.2 Middle East and Africa Rabies Vaccine Revenue by Country (2019-2030)
11.3 Middle East and Africa Rabies Vaccine Sales by Type (2019-2024)
11.4 Middle East and Africa Rabies Vaccine Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Rabies Vaccine Supply Chain Analysis
12.2 Rabies Vaccine Key Raw Materials and Upstream Suppliers
12.3 Rabies Vaccine Clients Analysis
12.4 Rabies Vaccine Sales Channel and Sales Model Analysis
12.4.1 Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Rabies Vaccine Distributors
13 Market Dynamics
13.1 Rabies Vaccine Industry Trends
13.2 Rabies Vaccine Market Drivers
13.3 Rabies Vaccine Market Challenges
13.4 Rabies Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer